Adoptive Infusion of Tolerogenic Dendritic Cells Prolongs the Survival of Pancreatic Islet Allografts: A Systematic Review of 13 Mouse and Rat Studies

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Sun, Guixiang ^a   Shan, Juan ^a   Li, Youping ^a   Zhou, Yanni ^a   Guo, Yingjia ^a   Wu, Wenqiao ^a   Yang, Tong ^a   Xia, Mengjuan ^a   Feng, Li ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CD40 LIGAND MONOCLONAL ANTIBODY; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; UNCLASSIFIED DRUG; VAF 347;

ADOPTIVE TRANSFER; ARTICLE; AUTOLOGOUS ALLOPEPTIDE PULSED TOLEROGENIC DENDRITIC CELL; CD4+ DENDRITIC CELL; CD8+ DENDRITIC CELL; CELL ACTIVITY; CHIMERA; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; DNA MODIFICATION; DONOR SPECIFIC T CELL HYPORESPONSIVENESS; EMBASE; GRAFT SURVIVAL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE DIFFERENTIATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MEDLINE; MESENCHYMAL STEM CELL; NONHUMAN; OUTCOME ASSESSMENT; PANCREAS ISLET CELL ALLOGRAFT; PANCREAS ISLET TRANSPLANTATION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL; TREATMENT OUTCOME;

ADOPTIVE TRANSFER; ANIMALS; DENDRITIC CELLS; GRAFT SURVIVAL; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; PYRIMIDINES; RATS; TRANSPLANTATION, HOMOLOGOUS;

RATTUS;

EID: 84871266077     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052096     Document Type: Article

References (31)

1. Shirasugi N, Adams AB, Durham MM, Lukacher AE, Xu H, et al. (2002) Prevention of chronic rejection in murine cardiac allografts: a comparison of chimerism- and nonchimerism-inducing costimulation blockade-based tolerance induction regimens. J Immunol 169: 2677-2684.
2. Mendieta-Zeron H, (2011) Developing immunologic tolerance for transplantation at the fetal stage. Immunotherapy 3: 1499-1512.
3. Ezzelarab M, Thomson AW, (2011) Tolerogenic dendritic cells and their role in transplantation. Semin Immunol 23: 252-263.
4. Kalantari T, Kamali-Sarvestani E, Ciric B, Karimi MH, Kalantari M, et al. (2011) Generation of immunogenic and tolerogenic clinical-grade dendritic cells. Immunol Res 51: 153-160.
5. Lo J, Clare-Salzler MJ, (2006) Dendritic cell subsets and type I diabetes: focus upon DC-based therapy. Autoimmun Rev 5: 419-423.
6. Giannoukakis N, Phillips B, Finegold D, Harnaha J, Trucco M, (2011) Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients. Diabetes Care 34: 2026-2032.
7. Steinman RM, Hawiger D, Nussenzweig MC, (2003) Tolerogenic dendritic cells. Annu Rev Immunol 21: 685-711.
8. Jonas S, Ayigari V, Viera D, Waterman P, (1999) Neuroprotection against cerebral ischemia: A review of animal studies and correlation with human trial results. Ann N Y Acad Sci 890: 2-3.
9. Zhang CT, Shan J, Feng L, Lu J, Xiao Z, et al. (2010) Effects of immunosuppressive drugs on CD4+CD25+ regulatory T cells: a systematic review of clinical and basic research. Chin J Evid-based Med 6: 740-748.
10. Stepkowski SM, Phan T, Zhang H, Bilinski S, Kloc M, et al. (2006) Immature syngeneic dendritic cells potentiate tolerance to pancreatic islet allografts depleted of donor dendritic cells in microgravity culture condition. Transplantation 82: 1756-1763.
11. Oluwole SF, Jin MX, Chowdhury NC, Engelstad K, Ohajekwe OA, et al. (1995) Induction of peripheral tolerance by intrathymic inoculation of soluble alloantigens: evidence for the role of host antigen-presenting cells and suppressor cell mechanism. Cell Immunol 162: 33-41.
12. Oluwole OO, Depaz HA, Gopinathan R, Ali A, Garrovillo M, et al. (2001) Indirect allorecognition in acquired thymic tolerance: induction of donor-specific permanent acceptance of rat islets by adoptive transfer of allopeptide-pulsed host myeloid and thymic dendritic cells. Diabetes 50: 1546-1552.
13. Hauben E, Gregori S, Draghici E, Migliavacca B, Olivieri S, et al. (2008) Activation of the aryl hydrocarbon receptor promotes allograft-specific tolerance through direct and dendritic cell-mediated effects on regulatory T cells. Blood 112: 1214-1222.
14. Huang Y, Chen P, Zhang CB, Ko GJ, Ruiz M, et al. (2010) Kidney-derived mesenchymal stromal cells modulate dendritic cell function to suppress alloimmune responses and delay allograft rejection. Transplantation 90: 1307-1311.
15. O'Rourke RW, Kang SM, Lower JA, Feng S, Ascher NL, et al. (2000) A dendritic cell line genetically modified to express CTLA4-IG as a means to prolong islet allograft survival. Transplantation 69: 1440-1446.
16. Kim YS, Yang SH, Kang HG, Seong EY, Lee SH, et al. (2006) Distinctive role of donor strain immature dendritic cells in the creation of allograft tolerance. Int Immunol 18: 1771-1777.
17. Chaib E, Brons IG, Papalois A, Calne RY, (1994) Does intrathymic injection of alloantigen-presenting cells before islet allo-transplantation prolong graft survival? Transpl Int 7 Suppl 1: S423-425.
18. Ali A, Garrovillo M, Jin MX, Hardy MA, Oluwole SF, (2000) Major histocompatibility complex class I peptide-pulsed host dendritic cells induce antigen-specific acquired thymic tolerance to islet cells. Transplantation 69: 221-226.
19. Yang DF, Qiu WH, Zhu HF, Lei P, Wen X, et al. (2008) CTLA4-Ig-modified dendritic cells inhibit lymphocyte-mediated alloimmune responses and prolong the islet graft survival in mice. Transpl Immunol 19: 197-201.
20. Zhu H, Qiu W, Lei P, Zhou W, Wen X, et al. (2008) IL-10 gene modified dendritic cells inhibit T helper type 1-mediated alloimmune responses and promote immunological tolerance in diabetes. Cell Mol Immunol 5: 41-46.
21. Li Q, Ge C, Liu R, Zhang K, Wu G, et al. (2010) Administration of dendritic cells dual expressing DcR3 and GAD65 mediates the suppression of T cells and induces long-term acceptance of pancreatic-islet transplantation. Vaccine 28: 8300-8305.
22. Rastellini C, Lu L, Ricordi C, Starzl TE, Rao AS, et al. (1995) Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 60: 1366-1370.
23. Conde E, Alegre L, Blanco-Sanchez I, Saenz-Morales D, Aguado-Fraile E, et al. (2012) Hypoxia inducible factor 1-alpha (HIF-1 alpha) is induced during reperfusion after renal ischemia and is critical for proximal tubule cell survival. PLoS One 7: e33258.
24. Roskott AM, Nieuwenhuijs VB, Dijkstra G, Koudstaal LG, Leuvenink HG, et al. (2011) Small bowel preservation for intestinal transplantation: a review. Transpl Int 24: 107-131.
25. Hsu FJ, Benike C, Fagnoni F, Liles TM, Czerwinski D, et al. (1996) Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 2: 52-58.
26. Hilkens CM, Isaacs JD, Thomson AW, (2010) Development of dendritic cell-based immunotherapy for autoimmunity. Int Rev Immunol 29: 156-183.
27. Liang X, Lu L, Chen Z, Vickers T, Zhang H, et al. (2003) Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival. Transplantation 76: 721-729.
28. Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ, (2004) Dendritic cell immunotherapy: mapping the way. Nat Med 10: 475-480.
29. Menger MD, Wolf B, Hobel R, Schorlemmer HU, Messmer K, (1991) Microvascular phenomena during pancreatic islet graft rejection. Langenbecks Arch Chir 376: 214-221.
30. Brissova M, Powers AC, (2008) Revascularization of transplanted islets: can it be improved? Diabetes 57: 2269-2271.
31. Wu WQ, Shan J, Li YP, Luo L, Sun GX, et al. (2012) Adoptive transfusion of tolerance dendritic cells prolong the survival of cardiac allograft: a systematic review on 44 animal studies. Chin J Evid-based Med 5: 139-153.